These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16408376)

  • 21. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

  • 22. Medical treatment of early breast cancer. III: chemotherapy.
    Smith I; Chua S
    BMJ; 2006 Jan; 332(7534):161-2. PubMed ID: 16424494
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose chemotherapy for breast cancer.
    Antman KH; Heitjan DF; Hortobagyi GN
    JAMA; 1999 Nov; 282(18):1701-3. PubMed ID: 10568629
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of neo-adjuvant sequential dose-dense chemotherapy doublets combined with trastuzumab in patients with HER-2-positive early stage breast cancer.
    Sánchez-Muñoz A; García-Tapiador AM; Dueñas-García R; Jaén-Morago A; Ortega-Granados AL; Martínez-Ortega E; Fernández Morales M; Fernández-Navarro M; de la Torre Cabrera C; Dueñas B; Ureña C; Martínez J; Morales F; Ramírez-Tortosa C; Sánchez-Rovira P
    Breast J; 2008; 14(5):506-7. PubMed ID: 18705667
    [No Abstract]   [Full Text] [Related]  

  • 25. Duration of adjuvant chemotherapy; anthracyclines, taxanes and novel agents--more or less.
    Barrett-Lee P; Ellis P; Bliss J;
    Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):263-6. PubMed ID: 12206635
    [No Abstract]   [Full Text] [Related]  

  • 26. Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer.
    Buzdar AU; Smith TL; Marcus CE; Hortobagyi GN; Blumenschein GR
    Recent Results Cancer Res; 1984; 96():141-7. PubMed ID: 6396767
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of anthracyclines in the adjuvant treatment of breast cancer.
    Lowenthal EA; Carpenter JT
    Cancer Treat Rev; 1995 May; 21(3):199-214. PubMed ID: 7656265
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose-response is alive and well.
    DeVita VT
    J Clin Oncol; 1986 Aug; 4(8):1157-9. PubMed ID: 3525764
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
    JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concepts and clinical trials of dose-dense chemotherapy for breast cancer .
    Orzano JA; Swain SM
    Clin Breast Cancer; 2005 Dec; 6(5):402-11. PubMed ID: 16381623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letter to the Editor re Yu and Holmgren. Traditional endpoint of progression-free survival (PFS) may not be appropriate for evaluating cytostatic agents combined with chemotherapy in cancer clinical trials.
    Mietlowski W; Wang J
    Contemp Clin Trials; 2007 Sep; 28(5):674. PubMed ID: 17449334
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose-dense adjuvant chemotherapy for primary breast cancer.
    Fornier M; Norton L
    Breast Cancer Res; 2005; 7(2):64-9. PubMed ID: 15743513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [High dose chemotherapy and stem cell transplant in patients with operable breast cancer and a poor prognosis; not indicated for the time being].
    Slee PH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(1):9-12. PubMed ID: 14750448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study.
    Therasse P; Mauriac L; Welnicka-Jaskiewicz M; Bruning P; Cufer T; Bonnefoi H; Tomiak E; Pritchard KI; Hamilton A; Piccart MJ;
    J Clin Oncol; 2003 Mar; 21(5):843-50. PubMed ID: 12610183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose density in breast cancer: a simple message?
    Lin NU; Gelman R; Winer EP
    J Natl Cancer Inst; 2005 Dec; 97(23):1712-4. PubMed ID: 16333021
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluorouracil and leucovorin in advanced breast cancer.
    Doroshow JH; Margolin K; Leong L; Akman S; Morgan R; Raschko J; Somlo G; Hamasaki V; Womack E; Newman E
    Adv Exp Med Biol; 1993; 339():187-93; discussion 195. PubMed ID: 8178716
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose intensity: a critique of a critical review.
    Hryniuk WM
    J Clin Oncol; 1989 May; 7(5):681-4. PubMed ID: 2651583
    [No Abstract]   [Full Text] [Related]  

  • 38. Dose-dense treatment prolongs disease-free survival of women with node positive breast cancer.
    Dang C; Seidman AD
    Cancer Treat Rev; 2003 Oct; 29(5):453-6. PubMed ID: 12972365
    [No Abstract]   [Full Text] [Related]  

  • 39. Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial.
    Elomaa I; Blomqvist C; Rissanen P; Mäntylä M
    Acta Oncol; 1988; 27(3):297-9. PubMed ID: 2970862
    [No Abstract]   [Full Text] [Related]  

  • 40. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B.
    Budman DR; Berry DA; Cirrincione CT; Henderson IC; Wood WC; Weiss RB; Ferree CR; Muss HB; Green MR; Norton L; Frei E
    J Natl Cancer Inst; 1998 Aug; 90(16):1205-11. PubMed ID: 9719081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.